Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01037452Phase 2Completed
A Phase 2 trial of lansoprazole, calcium carbonate, Magnesium hydroxide in gastroesophageal reflux disease (GERD), sponsored by Novartis. Started Dec 2009; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01037452.